| 000 | 01439 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512162743.0 | ||
| 264 | 0 | _c19700701 | |
| 008 | 197007s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jcem-30-5-646 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLawrence, A M | |
| 245 | 0 | 0 |
_aProgestins in the medical management of active acromegaly. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cMay 1970 |
||
| 300 |
_a646-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcromegaly _xdrug therapy |
| 650 | 0 | 4 | _aArginine |
| 650 | 0 | 4 |
_aCarcinoma _xchemically induced |
| 650 | 0 | 4 | _aDepression, Chemical |
| 650 | 0 | 4 |
_aEndometrial Hyperplasia _xchemically induced |
| 650 | 0 | 4 |
_aEstrogens _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFeminization _xchemically induced |
| 650 | 0 | 4 | _aGlucose Tolerance Test |
| 650 | 0 | 4 |
_aGrowth Hormone _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypothalamo-Hypophyseal System _xdrug effects |
| 650 | 0 | 4 | _aImmunoassay |
| 650 | 0 | 4 |
_aMedroxyprogesterone _xtherapeutic use |
| 650 | 0 | 4 |
_aMetrorrhagia _xchemically induced |
| 650 | 0 | 4 |
_aThromboembolism _xchemically induced |
| 700 | 1 | _aKirsteins, L | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 30 _gno. 5 _gp. 646-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jcem-30-5-646 _zAvailable from publisher's website |
| 999 |
_c5464023 _d5464023 |
||